Citation: Dm. Monroe et al., A POSSIBLE MECHANISM OF ACTION OF ACTIVATED FACTOR-VII INDEPENDENT OFTISSUE FACTOR, Blood coagulation & fibrinolysis, 9, 1998, pp. 15-20
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECTS OF ACTIVATED FACTOR-VII IN A CELL-BASED MODEL FOR TISSUE FACTOR-INITIATED COAGULATION, Blood coagulation & fibrinolysis, 9, 1998, pp. 21-25
Citation: M. Hoffman et al., ACTIVATED FACTOR-VII ACTIVATES FACTOR-IX AND FACTOR-X ON THE SURFACE OF ACTIVATED PLATELETS - THOUGHTS ON THE MECHANISM OF ACTION OF HIGH-DOSE ACTIVATED FACTOR-VII, Blood coagulation & fibrinolysis, 9, 1998, pp. 61-65
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
ROBERTS HR
Citation: M. Kjalke et al., ACTIVE SITE-INACTIVATED FACTORS VIIA, XA, AND IXA INHIBIT INDIVIDUAL STEPS IN A CELL-BASED MODEL OF TISSUE FACTOR-INITIATED COAGULATION, Thrombosis and haemostasis, 80(4), 1998, pp. 578-584
Authors:
CHANG JY
MONROE DM
OLIVER JA
LILES DK
ROBERTS HR
Citation: Jy. Chang et al., CLONING, EXPRESSION, AND CHARACTERIZATION OF MOUSE-TISSUE FACTOR PATHWAY INHIBITOR (TFPI), Thrombosis and haemostasis, 79(2), 1998, pp. 306-309
Authors:
LARSON PJ
CAMIRE RM
WONG D
FASANO NC
MONROE DM
TRACY PB
HIGH KA
Citation: Pj. Larson et al., STRUCTURE FUNCTION ANALYSES OF RECOMBINANT VARIANTS OF HUMAN FACTOR XA - FACTOR XA INCORPORATION INTO PROTHROMBINASE ON THE THROMBIN-ACTIVATED PLATELET SURFACE IS NOT MIMICKED BY SYNTHETIC PHOSPHOLIPID-VESICLES/, Biochemistry, 37(14), 1998, pp. 5029-5038
Citation: M. Hoffman et al., IGG FROM 2 PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME INCREASES THROMBIN GENERATION IN AN IN-VITRO CELL-BASED MODEL OF COAGULATION, Thrombosis and haemostasis, 1997, pp. 2-2
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
ROBERTS HR
Citation: M. Kjalke et al., COMPARISON OF THE EFFECTS OF ACTIVE SITE-INHIBITED FACTORS VIIA, XA, AND IXA IN A CELL-BASED MODEL FOR TISSUE FACTOR INITIATED COAGULATION, Thrombosis and haemostasis, 1997, pp. 40-40
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED FACTOR VIIA ON TISSUE FACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRIN TREATMENT, Thrombosis and haemostasis, 1997, pp. 44-44
Citation: Dm. Monroe et al., HIGH-DOSE FACTOR VIIA ACTIVATES FACTOR-X ON ACTIVATED PLATELETS IN THE ABSENCE OF TISSUE FACTOR, Thrombosis and haemostasis, 1997, pp. 681-681
Citation: Jy. Chang et al., MOUSE TFPI-BETA, AN ALTERNATIVELY SPLICED TISSUE FACTOR PATHWAY INHIBITOR, CONTAINS ONLY THE FIRST 2 KUNITZ-TYPE DOMAINS, Thrombosis and haemostasis, 1997, pp. 1542-1542
Citation: Jy. Chang et al., CLONING, EXPRESSION, AND PURIFICATION OF THE MOUSE-TISSUE FACTOR PATHWAY INHIBITOR (TFPI), Thrombosis and haemostasis, 1997, pp. 1654-1654
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED FACTOR VIIA ON TISSUE FACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRIN ADMINISTRATION, Thrombosis and haemostasis, 78(4), 1997, pp. 1202-1208
Authors:
LILES D
LANDEN CN
MONROE DM
LINDLEY CM
READ MS
ROBERTS HR
BRINKHOUS KM
Citation: D. Liles et al., EXTRAVASCULAR ADMINISTRATION OF FACTOR-IX - POTENTIAL FOR REPLACEMENTTHERAPY OF CANINE AND HUMAN HEMOPHILIA-B, Thrombosis and haemostasis, 77(5), 1997, pp. 944-948
Authors:
CHANG JY
MONROE DM
STAFFORD DW
BRINKHOUS KM
ROBERTS HR
Citation: Jy. Chang et al., REPLACING THE FIRST EPIDERMAL GROWTH FACTOR-LIKE DOMAIN OF FACTOR-IX WITH THAT OF FACTOR-VII ENHANCES ACTIVITY IN-VITRO AND IN CANINE HEMOPHILIA-B, The Journal of clinical investigation, 100(4), 1997, pp. 886-892
Citation: Av. Ciaccia et al., ARGININE-200 OF HEPARIN-COFACTOR-II PROMOTES INTRAMOLECULAR INTERACTIONS OF THE ACIDIC DOMAIN - IMPLICATION FOR THROMBIN INHIBITION, The Journal of biological chemistry, 272(22), 1997, pp. 14074-14079
Citation: Dm. Monroe et al., PLATELET ACTIVITY OF HIGH-DOSE FACTOR VIIA IS INDEPENDENT OF TISSUE FACTOR, British Journal of Haematology, 99(3), 1997, pp. 542-547
Citation: Ja. Oliver et al., ACTIVATED PLATELETS PROVIDE A SURFACE FOR THE ACTIVATION OF FACTOR-XIBY THROMBIN AND FACTOR XA, Blood, 90(10), 1997, pp. 111-111
Authors:
WOLBERG AS
HOFFMAN M
MONROE DM
ROBERTS HR
Citation: As. Wolberg et al., COMPETITION BETWEEN FACTOR-X AND FACTOR-IX FOR ACTIVATION BY F.VIIA TISSUE FACTOR (TF) - EFFECT ON THROMBIN (IIA) PRODUCTION IN A CELL-BASED MODEL/, Blood, 90(10), 1997, pp. 1292-1292
Authors:
WOLBERG AS
HOFFMAN M
MONROE DM
ROBERTS HR
Citation: As. Wolberg et al., DE-ENCRYPTION OF CELLULAR TISSUE FACTOR (TF) ACTIVITY INCREASES ACTIVATION OF BOTH FACTOR-IX AND FACTOR-X, Blood, 90(10), 1997, pp. 1293-1293
Citation: Jy. Chang et al., TFPI-BETA, A 2ND PRODUCT FROM THE HUMAN TISSUE FACTOR PATHWAY INHIBITOR (TFPI) GENE BY ALTERNATIVELY SPLICING, Blood, 90(10), 1997, pp. 1297-1297
Citation: Dk. Liles et al., THE FACTOR-VIII PEPTIDE CONSISTING OF AMINO-ACID-698 TO AMINO-ACID-712 ENHANCES FACTOR IXA CLEAVAGE OF FACTOR-X, Blood, 90(10), 1997, pp. 2054-2054
Authors:
PERERA L
LI LP
DARDEN T
MONROE DM
PEDERSEN LG
Citation: L. Perera et al., PREDICTION OF SOLUTION STRUCTURES OF THE CA2-BOUND GAMMA-CARBOXYGLUTAMIC ACID DOMAINS OF PROTEIN-S AND HOMOLOG GROWTH ARREST-SPECIFIC PROTEIN-6 - USE OF THE PARTICLE MESH EWALD METHOD(), Biophysical journal, 73(4), 1997, pp. 1847-1856